People · Operator

Thomas V. Croal

Named in public records as an officer, director or promoter · active 2009–2018 · Other Health Care, Other

4
Companies
5
Filings
$14.5M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Silverado Senior Living, Inc.Other Health CareSeries A$5.6M$113.1M2009
Silverado Southlake, LLCOther Health CareSeed$4.9M$73.9M2015
Silverado Senior Living Holdings, Inc.OtherSeed$2.2M$41.0M2018
Silverado Bellingham, LLCOther Health CareSeed$1.8M$45.0M2015
Operator network

Thomas V. Croal at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

VANCE R. CAESAR · 1 companies · 1 sharedVANCE R. CAESARJ. Christopher Lewis · 3 companies · 2 sharedJ. Christopher Le…Loren B. Shook · 4 companies · 4 sharedLoren B. ShookKelly Christopher Sheehy · 1 companies · 1 sharedKelly Christopher…Matt Christopher McQueen · 1 companies · 1 sharedMatt Christopher …Mercedes Christopher Kerr · 1 companies · 1 sharedMercedes Christop…Vance V. Caesar · 1 companies · 1 sharedVance V. CaesarSilverado Senior Living, Inc. · $5.6M raisedSilverado Senior Livi…Silverado Southlake, LLC · $4.9M raisedSilverado Southlake, …Silverado Senior Living Holdings, Inc. · $2.2M raisedSilverado Senior Livi…Silverado Bellingham, LLC · $1.8M raisedSilverado Bellingham,…Thomas V. CroalTC
Thomas V. Croal Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Thomas V. Croal on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Loren B. Shook44
J. Christopher Lewis23
Kelly Christopher Sheehy11
Mercedes Christopher Kerr11
Vance V. Caesar11
Matt Christopher McQueen11
VANCE R. CAESAR11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.